Navigation Links
Scleroderma Cure Still In Oscillation

According to a recent study, an old drug promises to slow down the progress of the dreadful autoimmune disease scleroderma or systemic sclerosis//.

About 3,00,000 Americans were found to be affected by the fatal disease Scleroderma, which destroys our system by hardening and thickening the skin and in many times it completely damages the lungs and other related organs. Nearly 80% of affected people have lung damaged more often it includes women only.

When comparing the benefits with after effects of a usual drug named cyclophosphamide, or Cytoxan, used to treat cancer and some autoimmune disorders, only minimum benefits were evidenced.

The study authors reported that 158 scleroderma patients from the country’s hospital were assigned at random into 2 groups, which includes experimental group (taking Cytoxan pills) and control group (taking only dummy pills) 1 per day for a period of 1 year. Throughout the year they were monitered, and the results show only a little improvement in using Cytoxan group of drugs although there seems a statistically significant difference – said Dr. Philip J. Clements, a rheumatologist at the University of California, Los Angeles, who was a co-author of the study.

One among the adverse effects of using Cytoxan group of drugs was low white blood cell count, says author.

Dr. Clements reported in an interview that beyond many studies Cytoxan with little side effects for scleroderma patients only proves in part to benefit scleroderma patients with lung damage.

Since having adverse effects in the long-term use of the drug, researchers urged to carry out a follow up of this study in a fast rate.


'"/>




Page: 1

Related medicine news :

1. Cancer Drug to Treat Scleroderma Lung Disease
2. Link between C-section Delivery and Stillbirth
3. Estimates For Number Of HIV/AIDS Deaths In India Still Not Available
4. People Still Neglect To Use Sunscreen In Spite Of Cancer Warnings
5. Past President Narayanans Condition Still Critical
6. LASIK Treatments Still To Reach Common Man
7. Hurricane Hangover: Katrina Still Haunts
8. Tuberculosis Is Still A Major Health Threat In Africa
9. Despite More Studies Researchers Are Still Confound With ADHD
10. Children Are Exercising Much Harder, But Are Still Obese
11. Study Shows That More Than 3 Million Stillbirths Occur Worldwide Every Year
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
Breaking Medicine Technology: